Analysis

  • The sustainable supply chain

    In 2006, 14 pharma companies came together to monitor standards in the supply chain, especially in the developing world. Chris Lo speaks to Pharmaceutical Supply Chain Initiative organiser Mark Little...

  • The patent cliff: rise of the generics

    Twenty blockbuster drugs are set to go off patent within the next few years, leading big pharma into a new era of R&D. Elisabeth Fischer finds out how major pharmaceutical...

  • The smart approach to pharma packaging

    The pharmaceutical industry is the perfect place for the packaging industry to show off some of its advanced technology. Chris Lo discovers how packaging concepts are helping patients to make...

  • Trial and error: site selection for clinical studies

    An often underrated process, site selection is one of the most significant factors for a successful clinical trial. Ahead of Arena International’s Achieve Operational Efficiency in Clinical Trials conference, Elisabeth...

  • Calling on contract manufacturing

    Outsourcing the pharmaceutical pipeline has become a popular option for companies big and small. Frances Cook talks to leading contract developer and manufacturer of pharmaceuticals Aesica about how the economic...

  • The cholesterol polypill – a global cure-all?

    Can a new cholesterol polypill open the door to a global mass preventative for cardiovascular diseases? Elisabeth Fischer speaks to Gilbert Thompson, emeritus professor of clinical lipidology at Imperial College,...

Close
Close
Close

Go Top